Esperion Therapeutics
ESPR
ESPR
164 hedge funds and large institutions have $99.2M invested in Esperion Therapeutics in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 56 increasing their positions, 41 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
-21
Holders Change %
-11.35%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
15
Increased
56
Reduced
41
Closed
34
Calls
$242K
Puts
$768K
Net Calls
-$526K
Net Calls Change
+$336K
Top Buyers
Top Sellers
1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$14M |
2 |
Morgan Stanley
New York
|
-$5.44M |
3 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
-$2.62M |
4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$1.54M |
5 |
![]()
JPMorgan Chase & Co
New York
|
-$1.34M |